This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Syneron's Elure™ Wins Allure Magazine's BEST OF BEAUTY Award For The Second Consecutive Year

YOKNEAM, Israel, Sept. 18, 2012 /PRNewswire/ -- Syneron Medical (NASDAQ: ELOS), www.syneron.com, the global leader in medical aesthetic products and technology, announced today that Allure Magazine has named elure™ Lotion its "Best Anti-Ager for Discoloration" in its annual Best of Beauty issue, which is published in October every year.  This is the second consecutive win for elure in Allure Magazine's Best of Beauty issue; elure™ Lotion and the elure™ Night Cream won the coveted award in the Big Breakthroughs category in October 2011.

(Logo:  http://photos.prnewswire.com/prnh/20120528/535447)

Allure Magazine selects their winners based on real, noticeable results. Among the thousands of beauty products launched every year, "these are the products that truly deliver," the magazine says, noting that elure Lotion is one of the only products readers need to know and own.

Louis Scafuri, Chief Executive Officer of Syneron, commented, "Due to its outstanding efficacy and safety profile, elure has rapidly become a leading home use solution recommended by physicians around the world for correcting skin discoloration.  We are thrilled and honored to receive this award from the leading beauty experts at Allure Magazine."

In addition to the Best of Beauty award, Allure Magazine also named elure Lotion one of "50 Beauty Products to Buy Before You Die".  Hailed as a "powerful skin-brightening cream," by Allure, dermatologist Leslie Baumann, M.D., a member of Syneron's Medical Advisory Board said, "my patients are seeing their hyperpigmentation fade within four weeks."

"elure is safe, simple-to-use and works well on all skin types," states Anne Chapas, M.D., dermatologist and Medical Director for Union Square Laser Dermatology in Manhattan, New York.  "Patients rightfully are enthusiastic when they experience quick results without irritation.  Within a month of regular use, skin appears brighter and more even toned."

See elure Lotion's Best of Beauty award for "Best Anti-Ager for Discoloration" in Allure Magazine's October 2012 issue. 

See elure Lotion highlighted as one of Allure Magazine's "50 Beauty Products to Buy Before You Die" here: http://www.allure.com/beauty-products/2012/beauty-products-to-buy-before-you-die#slide=44

For more information about elure's full range of products visit www.elureskin.com or follow us on Facebook: http://www.facebook.com/elureskin.

About Syneron Medical Ltd.

Syneron Medical Ltd. – a company devoted to real technology, real science and real results – is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. With its innovative approach to aesthetic treatments, Syneron has now entered into one of the largest in-demand applications, skin lightening. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

elure™ is sold as a topical cosmetic intended to beautify your skin and cosmetics are not subject to evaluation by the FDA. All product information provided is intended to be for informational purposes only. The information about skin conditions provided herein does not constitute medical or pharmaceutical advice and should not be relied upon as a substitute for qualified medical consultation with health professionals.

Additional information can be found at www.syneron.com

SOURCE Syneron Medical Ltd.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,076.27 +64.33 0.36%
S&P 500 2,114.07 +4.47 0.21%
NASDAQ 5,099.2310 +22.7070 0.45%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs